Clinical Trial Update: Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Childhood and Adolescent Essential Thrombocythemia [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial compares pegylated interferon alfa-2b with standard interferon alfa therapy in children and adolescents with essential thrombocythem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Thrombocytopenia

Drugs mentioned

• Interferon alfa therapy (interferon alfa)
• Pegylated Interferon Alfa-2b (pegylated interferon alfa-2b)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Essential Thrombocytopenia | Phase 2 | Status: RECRUITING